{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:06:17Z","timestamp":1747181177750,"version":"3.40.5"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T00:00:00Z","timestamp":1705622400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1,19]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Connective tissue disease (CTD) is a heterogeneous group of chronic inflammatory autoimmune disorders derived from a systemically auto-immunological deregulation. CTD may affect cardiac structures through multiple pathophysiological mechanisms, and subclinical cardiac injury is common. Heart failure (HF) is one of the common complications in these patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>Patients with CTD suffer an increased risk of cardiovascular disease and may have chest pain and shortness of breath.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>HF is characterized by dyspnea or exertional limitation due to impaired ventricular filling and\/or blood ejection. HF can be caused by other systemic diseases, not only by cardiovascular disorders but CTD. CTD may cause HF due to diffuse myocardial damage, heart valve damage, coronary ischemia, and so on.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The patient with catastrophic antiphospholipid syndrome take prednisone and warfarin. The patient with anti-synthetase syndrome was treated with immunoglobulin, followed by long-term oral medicines of prednisone, methotrexate, and folic acid.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The symptoms of chest pain and shortness of breath for patients with CTD improved.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>HF is one of the common complications in these patients with CTD, which has poor prognosis and severe aggravation. Once such patients experience chest pain, chest tightness, shortness of breath, etc, we should consider the possibility of HF. Early identification and correct treatment can delay the progression of HF, improve the prognosis, and enhance the quality of life for patients. Therefore, we should pay more attention to patients with CTD combined with HF.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000036885","type":"journal-article","created":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T21:03:32Z","timestamp":1705698212000},"page":"e36885","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Connective tissue disease as a challenge in heart failure: Three case reports"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4223-8864","authenticated-orcid":false,"given":"Ke","family":"Liu","sequence":"first","affiliation":[{"name":"Emergency Department of the Second Affiliated Hospital of ChongQing Medical University, Chongqing 400010, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuejiao","family":"Li","sequence":"additional","affiliation":[{"name":"Emergency Department of the Second Affiliated Hospital of ChongQing Medical University, Chongqing 400010, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the Second Affiliated Hospital of ChongQing Medical University, Chongqing 400010, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250505","doi-asserted-by":"crossref","first-page":"101462","DOI":"10.1016\/j.berh.2019.101462","article-title":"Autoantibodies in connective tissue disease.","volume":"34","author":"Mulhearn","year":"2020","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R2-20250505","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10741-019-09828-8","article-title":"Structural and myocardial dysfunction in heart failure beyond ejection fraction.","volume":"25","author":"Severino","year":"2020","journal-title":"Heart Fail Rev"},{"key":"R3-20250505","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"R4-20250505","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.1780330810","article-title":"The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis.","volume":"33","author":"Hunder","year":"1990","journal-title":"Arthritis Rheum"},{"key":"R5-20250505","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1001\/jama.2020.10262","article-title":"Heart failure with reduced ejection fraction: a review.","volume":"324","author":"Murphy","year":"2020","journal-title":"JAMA"},{"key":"R6-20250505","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1136\/ard.2004.025759","article-title":"Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome.","volume":"64","author":"Cervera","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R7-20250505","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.thromres.2009.11.025","article-title":"Lupus anticoagulant-hypoprothrombinemia syndrome (HLAS): report of one case in a familial infectious context.","volume":"126","author":"Appert-Flory","year":"2010","journal-title":"Thromb Res"},{"key":"R8-20250505","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1365-2796.2011.02362.x","article-title":"Antiphospholipid syndrome: laboratory detection, mechanisms of action and treatment.","volume":"270","author":"Tripodi","year":"2011","journal-title":"J Intern Med"},{"key":"R9-20250505","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S1474-4422(09)70239-X","article-title":"Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study.","volume":"8","author":"Urbanus","year":"2009","journal-title":"Lancet Neurol"},{"key":"R10-20250505","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/304177a0","article-title":"Myositis autoantibody inhibits histidyl-tRNA synthetase: a model for autoimmunity.","volume":"304","author":"Mathews","year":"1983","journal-title":"Nature"},{"key":"R11-20250505","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1080\/03009740510026526","article-title":"Clinical characteristics and outcomes of Takayasu\u2019s arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment, and angiographic classification.","volume":"34","author":"Park","year":"2005","journal-title":"Scand J Rheumatol"},{"key":"R12-20250505","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/CPM.0000000000000171","article-title":"The diagnosis and treatment of antisynthetase syndrome.","volume":"23","author":"Witt","year":"2016","journal-title":"Clin Pulm Med"},{"key":"R13-20250505","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.cardfail.2014.07.012","article-title":"Brief report: antisynthetase syndrome-associated myocarditis.","volume":"20","author":"Sharma","year":"2014","journal-title":"J Card Fail"},{"key":"R14-20250505","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nrrheum.2010.82","article-title":"Takayasu arteritis\u2014advances in diagnosis and management.","volume":"6","author":"Mason","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"R15-20250505","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00392-021-01893-0","article-title":"A 16-year-old girl with sudden heart failure and nephrotic syndrome associated with Takayasu\u2019s arteritis.","volume":"111","author":"Fang","year":"2022","journal-title":"Clin Res Cardiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000036885","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T20:04:05Z","timestamp":1746475445000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000036885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,19]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000036885","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2024,1,19]]}}}